How to Evaluate Whether Rivastigmine Patch Is Helping When a Caregiver Manages Treatment

Track weekly memory, tasks, and side effects to tell slowed decline from dose or patch problems.

Watch for stabilization or slower decline in memory, daily activities, and overall function over months, not sudden improvement. The rivastigmine patch, a skin patch that delivers an acetylcholinesterase inhibitor, helps some people hold skills longer rather than restoring lost ability.

DailyMed from the U.S. National Library of Medicine lists it for mild, moderate, and severe Alzheimer's dementia plus mild-to-moderate Parkinson's disease dementia DailyMed listing. The Alzheimer's Association notes these memory drugs only temporarily ease symptoms such as memory, language, and judgment and do not cure or stop Alzheimer's Alzheimer's Association medication guide.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Table of Contents

What counts as benefit in trials?

In 24-week trials, FDA-approved labeling measured two kinds of change together. Cognition was tested with ADAS-Cog, a scored memory and thinking test. Overall change and daily function were rated with ADCS-CGIC and ADCS-ADL.

The average drug-placebo difference on ADAS-Cog was about 1.8 to 2.9 points, according to FDA-approved labeling FDA-approved labeling. That is a small average shift, not a return to normal. For a caregiver, the practical meaning is steadier performance, not sharp gains.

How can you track daily change?

Pick three or four repeatable situations and record them weekly. Note the date, patch dose, sleep, illness, and who observed. Compare the same task over weeks, not day to day.

  • Memory cues: needs one reminder versus repeated reminders for meals, names, or appointments.
  • Daily tasks: dresses, eats, bathes, or uses the phone with less help or fewer steps repeated.
  • Household participation: follows a familiar recipe, folds laundry, or stays engaged longer.
  • Orientation and language: finds the bathroom, follows short instructions, or loses words less often.

Is the dose and patch routine right?

A patch cannot be judged if dosing and placement vary. The National Library of Medicine DailyMed describes a start of 4.6 mg per 24 hours daily. If tolerated after at least four weeks, the dose rises to 9.5 mg per 24 hours as the minimum effective dose, then after four more weeks to a maximum of 13.3 mg per 24 hours.

The Novartis Exelon FDA package insert directs one patch daily on clean, dry, hairless skin of the upper or lower back, upper arm, or chest. Rotate sites daily, avoid reuse of a site within 14 days, and use the back if the person pulls patches off. Poor adhesion, missed days, heat exposure, or cutting a patch can blur the picture.

When should you call the prescriber?

Call promptly for nausea, vomiting, diarrhea, appetite loss, weight loss, dehydration, dizziness, or skin reactions spreading beyond the patch. The Novartis Exelon FDA package insert via MedLibrary advises prompt reporting because dose adjustment or stopping may be needed. Do not adjust the dose alone after vomiting, fainting, marked weight loss, or dehydration.

Allow enough time before judging lack of help. The VA dementia caregiver guide, citing the Alzheimer's Association, frames the goal as slowed progression over 6 to 12 months VA dementia caregiver guide. Bring your weekly log, patch site notes, weight changes, and a list of new drugs or illnesses to that review.


You Might Also Like

HelpDementia.com

Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance

© 2026 HelpDementia.com. All rights reserved.

Educational information only. It is not medical advice and does not replace care from a qualified clinician.